Result of AGM

About this update from Cambridge Cognition Holdings Plc

27 June 2025   Cambridge Cognition Holdings plc (" Cambridge Cognition" , the "Company" or the "Group")   Result of AGM   Cambridge Cognition Holdings plc, the brain health software group specialising in digital health products that advance brain health research and treatment, held its Annual General Meeting ("AGM") earlier today at the registered office of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU and announces that all resolutions put forward were duly passed.   Proxy votes were received in respect of 67.6% of the Company's issued share capital. The votes cast were as follows:     Resolution Votes For Percent of votes cast For Votes Against Percent of votes cast Against Votes Withheld 1 To approve the 2024 Report and Accounts 28,372,450 100% - - - 2 To approve the 2024 Directors' Remuneration Report 1 28,346,127 99.91% 25,315 0.09% 1,008 3 To approve the Directors' Remuneration Policy 1 28,346,127 99.91% 25,315 0.09% 1,008 4 To re-appoint the auditors 28,359,763 99.99% 3,500 0.01% 9,187 5 To authorise the directors to set the auditors' remuneration 28,370,475 100% - - 1,975 6 To re-elect Steven Powell as a director 28,369,043 100% - - 3,407 7 To re-elect Richard Bungay as a director 24,074,907 100% - - 4,297,543 8 To re-elect Stuart Gall as a director 28,371,018 100% - - 1,432 9 To re-elect Debra Leeves as a director 24,074,907 100% - - 4,297,543 10 To re-elect Nick Rodgers as a director 28,371,018 100% - - 1,432 11 To elect Jon Kempster as a director 28,371,018 100% - - 1,432 12 Authority to allot shares 28,340,996 99.89% 30,446 0.11% 1,008 13 Authority to disapply pre-emption rights 2 28,323,483 99.83% 47,959 0.17% 1,008 14 Authority to purchase own shares on the market 2 24,925,895 99.84% 39,143 0.16% 3,407,412     Notes 1.  Indicates an advisory vote. 2.  Indicates a Special Resolution requiring 75% of votes cast to be carried.     Enquiries:     Cambridge Cognition Holdings plc   Tel: 012 2381 0700 Rob Baker, Joint Managing Director and Chief Operating Officer [email protected]     Panmure Liberum Limited (NOMAD and Joint Broker) Tel: 020 7886 2968 Freddy Crossley / Will Goode / Mark Rogers (Corporate Finance) Rupert Dearden (Corporate Broking)     Dowgate Capital Limited (Joint Broker) Tel: 020 3903 7715 David Poutney / Amber Higgs Hudson Sandler (Financial PR and IR ) Dan de Belder / Hattie Dreyfus / Jackson Redley   Tel: 020 7796 4133 [email protected]   Notes to Editors   About Cambridge Cognition Cambridge Cognition is a brain health software group specialising in digital health products that advance brain health research and treatment.   Built on rich, curated data and deep technical expertise we are building a strong global brand with scalable technology that will support the rising world demand for diagnosing and treating brain health. The Company creates shareholder value through organic sales growth, strategic partnerships, joint ventures, and spinouts. The Company has identified four market sectors: ·      Clinical Studies for new pharmaceuticals; ·      Academic Research for scientists to understand CNS disorders; ·      Healthcare to provide physicians with cognitive assessments to allow them to diagnose and treat patients; and, ·      Consumer Health & Wellness to provide individuals access to accurate, reliable, and meaningful data to assess their cognitive health.   For further information, visit: www.cambridgecognition.com/

View stock analysis, news, and events for Cambridge Cognition Holdings Plc